Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05010265 · ClinicalTrials.gov registry record
An Ethical Approach to Detecting Covert Consciousness
A clinical trial of Disorder of Consciousness, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- 70
- Enrollment target
- 1
- Study location
NCT05010265: Recruiting study of Disorder of Consciousness, sponsored by Massachusetts General Hospital.
NCT05010265 is a study of Disorder of Consciousness that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 70 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05010265, a study of Disorder of Consciousness, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to develop an ethical approach to developing and deploying novel neurotechnologies to aid in the detection of consciousness and prediction of recovery after brain injury.
Primary Outcome
Capture and evaluate salient perspectives, preferences and values surrounding the use of advanced neurotechnologies to detect consciousness and predict recovery
Conditions Studied
Interventions
- OTHER Clinician Questionnaire
- OTHER Semi Structured Interviews
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2027-07 |
What NCT05010265 shows while recruiting
NCT05010265 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 1 condition, with Disorder of Consciousness appearing as the primary indexed condition, and to 2 interventions - of which Clinician Questionnaire is the first listed.
NCT05010265 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05010265 about?
NCT05010265 is a clinical study titled "An Ethical Approach to Detecting Covert Consciousness". This study aims to develop an ethical approach to developing and deploying novel neurotechnologies to aid in the detection of consciousness and prediction of recovery after brain injury.
What is the current status of trial NCT05010265?
This trial is currently recruiting. The enrollment target is 70 participants. The study started on 2022-02-01. Estimated completion is 2027-07.
What conditions does trial NCT05010265 study?
This clinical trial studies the following conditions: Disorder of Consciousness.
What interventions are being tested in trial NCT05010265?
The interventions under investigation include: Clinician Questionnaire (OTHER), Semi Structured Interviews (OTHER).
Who is sponsoring clinical trial NCT05010265?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05010265 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Disorder of Consciousness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI